Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.50
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.704%)
Open: 13.75
High: 13.75
Low: 13.75
Prev. Close: 13.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

Thu, 04th Jan 2024 16:54

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

The FTSE 100 index closed up 40.74 points, 0.5%, at 7,723.07. The FTSE 250 ended up 45.65 points, 0.2%, at 19,372.05, and the AIM All-Share closed up 1.79 points, or 0.2%, at 755.94.

The Cboe UK 100 ended up 0.6% at 771.71, the Cboe UK 250 closed up 0.6% at 16,874.97, and the Cboe Small Companies ended up 0.5% at 14,940.05.

Stocks in New York were higher at the London equities close, with the DJIA up 0.7%, the S&P 500 index up 0.4%, and the Nasdaq Composite up 0.2%.

Since the new year, eyes have been on the US economy and where interest rates may go in 2024.

On Wednesday evening, investors had the minutes from the latest US Federal Reserve meeting, back in December.

At the December meeting, the rate-setting Federal Open Market Committee agreed to hold its benchmark rate steady in a range between 5.25% and 5.5%. Members indicated that they expect three quarter-percentage point cuts by the end of 2024.

"In discussing the policy outlook, participants viewed the policy rate as likely at or near its peak for this tightening cycle, though they noted that the actual policy path will depend on how the economy evolves," the highly anticipated minutes stated.

Officials "reaffirmed that it would be appropriate for policy to remain at a restrictive stance for some time until inflation was clearly moving down sustainably."

On Thursday, focus has been on the health of the US labour market.

The US labour market added more jobs than expected in December, according to a tracker from payroll processing firm ADP.

ADP said sector employment increased by 164,000 jobs in December, picking up from a 101,000 rise in November and ahead of the FXStreet cited consensus of 115,000. The November total of jobs added was revised from 103,000 to 101,000.

Meanwhile, US new jobless claims fell by more than expected in the most recent week.

According to the US Department of Labor, new jobless claims totalled 202,000 in the week ended December 30. This is down from last week's revised level of 220,000. The latest reading came in lower than FXStreet-cited consensus of 216,000.

The data is out ahead of the US nonfarm payrolls Friday.

Meanwhile, in European equities on Thursday, the CAC 40 in Paris and the DAX 40 in Frankfurt both ended up 0.5%.

According to Destatis, Germany's annual inflation picked up to 3.7%, from 3.2% in November. This came in slightly behind FXStreet market consensus of 3.8%.

Capital Economics' Andrew Kenningham commented: "The jump in Germany's headline inflation rate in December came as no surprise as it was driven by energy price subsidies introduced more than a year ago. With core inflation continuing to trend down, it should not affect investors' expectations for the [European Central Bank] to begin cutting interest rates in the coming months."

The pound was quoted at USD1.2696 at the London equities close Thursday, up compared to USD1.2646 at the close on Wednesday. The euro stood at USD1.0961 at the European equities close Thursday, higher against USD1.0915 at the same time on Wednesday. Against the yen, the dollar was trading at JPY144.48, up compared to JPY143.50 late Wednesday.

In the FTSE 100, retailers Next and JD Sports were the best and worst performing blue-chip stocks respectively, after both provided trading updates including the Christmas period.

JD Sports Fashion plummeted 23%, after cutting its profit outlook amid weaker-than-expected sales growth and gross margins.

The retailer said organic revenue was up 6.0% in the 22 weeks that ended December 30 on a constant currency basis from a year earlier, with like-for-like growth of 1.8%. This was slightly behind its expectations. The retailer expects organic revenue growth of around 8% for the year ending February 3.

As a result, it expects to report pretax profit and adjusted items of between GBP915 million and GBP935 million for the financial year. This falls short of market expectations of GBP1.04 billion, which back in September, JD Sports had said it expected to meet.

Next rose 5.5%, on the back of its trading update.

"Clothing retailer Next has set the bar high for the rest of the retail sector by posting a strong trading update this morning," Edison analyst Russell Pointon commented.

In the nine weeks to December 30, the clothing and homewares seller's full price sales were 5.7% higher year-on-year, some GBP38 million better than its previous guidance. It had expected growth of 2.0% year-on-year. The period forms part of its fourth quarter, which concludes on January 27.

The company now expects pretax profit for financial 2024 of GBP905 million, a lift of GBP20 million from its previous outlook, and it would represent a year-on-year increase of 4.0%. Next had initially expected pretax profit of GBP795 million, but it has, now on a number of occasions, lifted its bottom line outlook.

Meanwhile, BP and Shell rose 0.5% and 0.2%, respectively, as oil prices extended their recent upward movements on concerns over the Middle East.

"The region remains a tinder box due to the Israel-Gaza war, and disruption to shipping routes through the Red Sea is also a key factor behind the surge in crude," AJ Bell's investment director Russ Mould explained.

Brent oil was quoted at USD76.60 a barrel at the London equities close Thursday, down from USD78.13 late Wednesday. Over the last week the price has hit highs of USD79.83.

On London's AIM, Angle shares more than doubled to 31.40 pence.

The Surrey-based medical diagnostics provider celebrated "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Gold was quoted at USD2,0445.01 an ounce at the London equities close Thursday, up against USD2,038.89 at the close on Wednesday.

In Friday's UK corporate calendar, MTI Wireless Edge will hold its extraordinary general meeting regarding proposed grant of options to the directors.

The economic calendar for Friday has eurozone inflation readings at 1000 GMT. Before that, there is the UK Halifax house price index at 0700 GMT.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
16 Dec 2011 10:37

Angle shares storm north on Parsortix lung cancer result

Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix. Parsortix, which specialises in medical diagnostics, has confirmed its cell separation device can "capture cultured lung cancer cells". This comes af

Read more
16 Nov 2011 16:00

Angle reports further delays on IVF product

Shares in Angle, the Surrey-based technology investment firm, fell today after it reported delays to its IVF product EmbryoSure. The embryo viability product is being developed by Novocellus, which is 82% owned by Angle. The firm had already said the trial of EmbryoSure was delayed, but today adde

Read more
11 Nov 2011 08:21

Angle prostate cancer test sees shares rocket

Angle, the Surrey-based technology investment firm, has seen its share price rocket nearly 15% on news one of its divisions has found a new way to detect prostate cancer. Parsortix, which is 90% owned by Angle, claims its "separation technology" can capture prostate cancer cells added to blood. T

Read more
5 Oct 2011 14:01

Angle buys 90% stake in cancer diagnostic firm

Angle has increased its stake in its subsidiary, Parsotix, to 90% following the success of the cancer diagnostic firm's cell separation device. The fund the move, Angle raised £1.25m in July, 80% of which has been allocated to Parsortix to fund the definitive validation of its initial findings, wh

Read more
28 Sep 2011 08:38

Angle announces new cancer detection device

Technology firm Angle has announced that Parsortix, its 85% owned portfolio company which specialises in medical diagnostics, has achieved a major milestone by validating that its cell separation device can capture cancer cells added to blood. Parsortix's patented cell separation device can be used

Read more
23 Aug 2011 12:12

Angle rises sharply on patent award

Technology firm incubator Angle saw an acute increase in its share price after one of its subsidiaries was granted a US patent. Angle's 83% owned medical diagnostics company Parsortix has been issued a US patent relating to its technology for particle and cell separation, identification, sorting an

Read more
29 Jul 2010 08:21

Angle FY10 Loss Narrows, To Focus On Cash Resources, Cost Cuts

LONDON (Dow Jones)--Angle PLC (AGL.LN), an international Ventures and Management services company, Thursday reported a much narrowed fiscal 2010 pretax loss and said it continues to focus on the level of cash resources available to it and will continue to reduce its cost base and seek new management

Read more
26 Jul 2010 17:14

Angle investment secures high profile partner

Technology consultancy and investment company Angle says that its portfolio company Geomerics has agreed a corporate partnership with one of the world's leading technology companies. The partner will invest up to £2.3m in Geomerics, of which £1m is dependent on milestones being achieved. Angle cu

Read more
26 Jul 2010 08:24

Angle: Geomerics Corporate Partnership With Technology Company

LONDON (Dow Jones)--Angle PLC (AGL.LN), an international venture management company focusing on the commercialization of technology and innovation, said Monday that its portfolio company Geomerics Ltd, which specializes in computer games middleware, has agreed to a corporate partnership with a techn

Read more
16 Jul 2010 11:42

Small caps round-up: Judges Scientific, Terra Catalyst, DCC

Judges Scientific said trading activity during the six-month ended 30 June remained robust and benefited from a healthy opening order book, strong order intake and favourable exchange rates. Order intake during the half-year was much stronger than in the comparable period of 2009. Terra Catalyst Fu

Read more
16 Jul 2010 07:31

Angle: NeuroTargets Makes Progress, Gets GBP3.8M Phase 2 Funding

LONDON (Dow Jones)--Angle PLC (AGL.LN), an international venture management company focusing on the commercialization of technology and innovation, Friday announces strong progress with NeuroTargets, its 25% portfolio company specializing in the relief of neuropathic pain, with the Wellcome Trust ag

Read more
24 Sep 2009 17:14

Grid finance chief sells again

Gas and electricity network operator National Grid has sailed through the turbulence of the past year relatively unscathed. The share price now is still lower than this time in 2008, but has bounced strongly since April and finance director Steve Lucas is taking advantage to sell his second chunk

Read more
24 Jul 2009 17:13

London close: Ten out of ten for Footsie

The FTSE 100 index made it ten days of rises in a row, despite tailing off towards the close as investors looked to bank profits ahead of the week-end. It capped the best rally by the blue-chip index in five years. The rise was achieved despite dismal gross domestic product data. UK output contract

Read more
24 Jul 2009 14:11

London afternoon: Financials find favour

Footsie eased back a little over the lunchtime session but thanks to firm financials the blue-chip index continues to shrug off this morning's gloomy data on gross domestic product (GDP). UK output contracted 0.8% between April and June after a 2.4% decline in the first quarter, according to the Of

Read more
24 Jul 2009 11:54

London midday: London shrugs off GDP shock

After a shaky opening the market is moving steadily ahead, despite receiving a jolt from much worse than expected gross domestic product (GDP) figures. Output contracted 0.8% between April and June after a 2.4% decline in the first quarter, according to the Office for National Statistics' flash est

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.